This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Is Cimpress (CMPR) Down 6.5% Since Last Earnings Report?
by Zacks Equity Research
Cimpress (CMPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Improve Your Portfolio with this Filtered Zacks Rank Stock Screener
by Benjamin Rains
Let's see how our Filtered Zacks Rank 5 Screener helps add two relatively simple filters to our Zacks Rank #1 criteria to help narrow the list of stocks and try to boost performance...
Here's Why Rent-A-Center Stock Remains an Investor Favorite
by Zacks Equity Research
Rent-A-Center's (RCII) e-commerce-enhancement initiatives are encouraging. Its Preferred Lease unit is also performing well.
SP Plus (SP) Surges: Stock Moves 6.4% Higher
by Zacks Equity Research
SP Plus (SP) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Wolverine's (WWW) Q2 Earnings & Sales Beat, Decline Y/Y
by Zacks Equity Research
Wolverine (WWW) delivers better-than-expected second-quarter 2020 results. However, the top line was hurt by the pandemic.
Central Garden (CENT) Q3 Earnings & Sales Beat Estimates
by Zacks Equity Research
Central Garden's (CENT) third-quarter fiscal 2020 results reflect gains from robust portfolio, leading to growth across segments, as well as contributions from recent acquisitions.
Rent-A-Center (RCII) Beats Q2 Earnings & Revenue Estimates
by Zacks Equity Research
Robust same-store sales and contributions from the buyout of Merchants Preferred aided Rent-A-Center's (RCII) second-quarter 2020 results.
Cimpress (CMPR) Q4 Earnings Miss Estimates, Decline Y/Y
by Zacks Equity Research
Cimpress' (CMPR) fourth-quarter fiscal 2020 revenues hurt by lackluster performance across its segments.
Cimpress (CMPR) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Cimpress (CMPR) delivered earnings and revenue surprises of -30.65% and 2.02%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Cimpress (CMPR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cimpress (CMPR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Avoid Betting on Cimpress (CMPR) Now
by Zacks Equity Research
Cimpress (CMPR) has been suffering from low bookings across its segments due to the soft-demand environment amid the coronavirus outbreak. Also, the company's high debt level remains concerning.
Cimpress (CMPR) to Gain From Acquisitions Despite Headwinds
by Zacks Equity Research
Cimpress (CMPR) is likely to benefit from strong product portfolio, acquired assets and shareholder-friendly policies. However, high debt and the coronavirus outbreak-related issues are concerning.
Cimpress' Financial Results Update Shows Y/Y Drop in Bookings
by Zacks Equity Research
Cimpress' (CMPR) consolidated bookings for April and May decline on a y/y basis.
Cimpress (CMPR) Up 18.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Cimpress (CMPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cimpress (CMPR) Declines 38% YTD: What's Hurting the Stock?
by Zacks Equity Research
Cimpress (CMPR) is experiencing low bookings across its segments on account of the coronavirus outbreak-led market downturn. Also, its high debt level and low liquidity remain concerning.
Cimpress (CMPR) Q3 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Cimpress' (CMPR) third-quarter fiscal 2020 revenues decrease y/y on account of lackluster performance across most of its segments.
Cimpress (CMPR) Beats Q3 Earnings Estimates
by Zacks Equity Research
Cimpress (CMPR) delivered earnings and revenue surprises of 15.09% and -0.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Cimpress (CMPR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Cimpress (CMPR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cimpress (CMPR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Cimpress (CMPR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for April 22nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Cimpress Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Cimpress has been struggling lately, but the selling pressure may be coming to an end soon.
Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress
by Zacks Equity Research
Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress
What Bargain Hunting? Tap 5 Stocks With Rising P/E
by Sanghamitra Saha
Bet on these top-ranked stocks with rising P/E to realize outsized gains.
G-III Apparel (GIII) Stock Gains on Earnings Beat in Q4
by Zacks Equity Research
G-III Apparel (GIII) posts robust fourth-quarter fiscal 2020 earnings on impressive brand strength and strategic efforts. It did not provide outlook for fiscal 2021 due to the coronavirus crisis.
3 Stocks Witnessing Momentum Anomaly Amid Coronavirus Crisis
by Zacks Equity Research
These fast movers are currently witnessing a short-term pullback in price, as COVID-19 pandemic rattles market. So, this could essentially be a great entry point for higher returns.